ChemicalBook > CAS DataBase List > AZD 1080

AZD 1080

Product Name
AZD 1080
CAS No.
612487-72-6
Chemical Name
AZD 1080
Synonyms
CS-809;AZD1080;AZD-1080;AZD 1080;AZD1080 ,S7145;AZD 1080;AZD-1080;AZD 1080 USP/EP/BP;AZD1080, 10 mM in DMSO;AZD1080 AZD-1080 GSK-3 Inhibitor;2-Hydroxy-3-(5-(morpholinomethyl)pyridin-2-yl)-1H-indole-5-carbonitrile
CBNumber
CB72666593
Molecular Formula
C19H18N4O2
Formula Weight
334.37
MOL File
612487-72-6.mol
More
Less

AZD 1080 Property

Boiling point:
594.0±50.0 °C(Predicted)
Density 
1.40±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL in DMSO
form 
solid
pka
8.32±0.50(Predicted)
color 
Light yellow to orange
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML3776
Product name
AZD1080
Purity
≥98% (HPLC)
Packaging
5mg
Price
$194.75
Updated
2025/07/31
Sigma-Aldrich
Product number
SML3776
Product name
AZD1080
Purity
≥98% (HPLC)
Packaging
25mg
Price
$824
Updated
2025/07/31
Cayman Chemical
Product number
16676
Product name
AZD 1080
Purity
≥95%
Packaging
1mg
Price
$29
Updated
2024/03/01
Cayman Chemical
Product number
16676
Product name
AZD 1080
Purity
≥95%
Packaging
5mg
Price
$102
Updated
2024/03/01
Cayman Chemical
Product number
16676
Product name
AZD 1080
Purity
≥95%
Packaging
10mg
Price
$145
Updated
2024/03/01
More
Less

AZD 1080 Chemical Properties,Usage,Production

Description

The two isoforms of glycogen synthase kinase 3, GSK3α and GSK3β, constitutively phosphorylate and inactivate glycogen synthase, preventing glycogen synthesis. They also phosphorylate proteins that are relevant to Alzheimer’s disease and osteogenesis. AZD 1080 is a potent, brain permeable inhibitor of GSK3α and GSK3β (Kis = 6.9 and 31 nM, respectively). It shows >14-fold selectivity against several kinases, receptors, enzymes, and ion channels. AZD 1080 inhibits tau phosphorylation in cells. It shows good bioavailability after oral administration in vivo, inhibiting hippocampal tau phosphorylation and reversing cognitive deficits induced by the NMDA receptor antagonist (+)-MK-801 . In humans, oral AZD 1080 inhibits GSK3 activity in peripheral blood lymphocytes following an initial delay in response.

Uses

AZD1080 is a selective, orally active, brain permeable glycogen synthase kinase-3 (GSK3) inhibitor (1,2). AZD1080 has shown to rescue synaptic plasticity deficits in rodent brain and exhibit peripheral target engagement in humans.

Definition

ChEBI: AZD1080 is a member of the class of hydroxyindoles that is 1H-indole substituted by hydroxy, 5-(morpholin-4-ylmethyl)pyridin-2-yl, and cyano groups at positions 2, 3 and 5, respectively. It is a potent, brain permeable inhibitor of human GSK3alpha and GSK3beta with Ki of 6.9 nM and 31 nM, respectively. The drug was being developed by AstraZeneca for the treatment of Alzheimer's disease (clinical trial now discontinued). It has a role as an EC 2.7.11.26 (tau-protein kinase) inhibitor, a tau aggregation inhibitor, an antineoplastic agent and an apoptosis inducer. It is a member of morpholines, a member of pyridines, a member of hydroxyindoles, a nitrile and a tertiary amino compound.

Synthesis

612488-09-2

557-21-1

612487-72-6

The reaction was carried out in a 10 mL Schlenk tube with 5-bromo-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]-1H-indol-2-ol (1.00 g, 2.57 mmol), zinc powder (25.5 mg, 0.386 mmol), and bis(dibenzylideneacetone)palladium(0) (37 mg, 0.064 mmol). First, the reaction was added to the Schlenk tube along with a magnetic stirring bar, followed by sealing with a rubber septum, evacuating and displacing twice with nitrogen. Next, degassed dimethylformamide (7 mL) was added via syringe, followed by tri-tert-butylphosphine (65 μL, 20% w/v toluene solution, 0.064 mmol). The reaction mixture was heated to 50 °C with stirring and held for 4 min before zinc cyanide (169 mg, 1.42 mmol) was added under nitrogen protection. The reaction was continued with stirring at 50 °C for 3 h. HPLC analysis showed complete conversion of the reaction. After completion of the reaction, the mixture was cooled to room temperature and filtered through a sintered glass filter. To the filtrate, 3-mercaptopropyl functionalized silica (0.3 g) was added and the mixture was stirred at 40 °C overnight and filtered again. The filtrate was heated to 60 °C and tetrasodium acetate-sodium ethylenediaminetetraacetic acid (25 mL, 0.30 M aqueous solution) was added over 5 min to produce a bright yellow precipitate. The mixture was cooled to room temperature and filtered, the precipitate was washed with water (10 mL) and dried under vacuum at 40 °C to afford the target product 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]-1H-indole-5-carbonitrile (0.63 g, 73% yield). The product characterization data was consistent with Example 5.

in vivo

The pharmacokinetic analysis in blood after oral administration revealed that AZD1080 has a good oral bioavailability in rats (15-24%) with a half-life of 7.1 h, making AZD1080 attractive for further in vivo testing. The subchronic (3 days) oral treatment with AZD1080 at 4 or 15 μmol/kg significantly blocked the MK-801-induced memory deficit (AZD1080 vs. MK-801, p<0.05 at 4 μmol/kg and p<0.01 at 15 μmol/kg) in mice, raising the hypothesis that longer treatment may be required to prime the synapses to function effectively[1].

target

GSK-3α

IC 50

GSK-3α: 8.2 (pKi); GSK-3β: 7.5 (pKi); cdk5: 6.4 (pKi); cdk2: 5.9 (pKi); cdk1: 5.7 (pKi)

References

[1] georgievska b1, sandin j, doherty j, mörtberg a, neelissen j, andersson a, gruber s, nilsson y, schött p, arvidsson pi, hellberg s, osswald g, berg s, fälting j, bhat rv. azd1080, a novel gsk3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans. j neurochem. 2013 may;125(3):446-56.

AZD 1080 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

AZD 1080 Suppliers

Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
96815
Advantage
76
Jinan Trio PharmaTech Co., Ltd.
Tel
0531-88811783
Fax
+86 (531) 55696010 QQ 1762738062
Email
sales@trio-pharmatech.com
Country
China
ProdList
1856
Advantage
62
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Country
United States
ProdList
12952
Advantage
65
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
sales@meilune.com
Country
China
ProdList
4747
Advantage
58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66113011 17798518460
Fax
(1)02557626880
Email
cfzhang@aikonchem.com
Country
China
ProdList
19913
Advantage
55
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-6206333 13167063860
Fax
021-50323701
Email
anhua.mao@aladdin-e.com
Country
China
ProdList
25003
Advantage
65
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
More
Less

View Lastest Price from AZD 1080 manufacturers

Career Henan Chemical Co
Product
AZD 1080 612487-72-6
Price
US $2.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
100kg
Release date
2018-12-24

612487-72-6, AZD 1080Related Search:


  • CS-809
  • AZD 1080;AZD-1080
  • AZD 1080
  • AZD1080
  • AZD-1080
  • 2-Hydroxy-3-(5-(morpholinomethyl)pyridin-2-yl)-1H-indole-5-carbonitrile
  • 2-Hydroxy-3-[5-[(morpholin-4-yl)methyl]pyridin-2-yl]-1H-indole-5-carbonitrile
  • 2-Hydroxy-3-[5-[(morpholin-4-yl)methyl]pyridin-2-yl]-1H-indole-5-carbonitrile AZD1080
  • 2-hydroxy-3-[5-(4-morpholinylmethyl)-2-pyridinyl]-1H-indole-5-carbonitrile
  • AZD 1080 USP/EP/BP
  • AZD1080 AZD-1080 GSK-3 Inhibitor
  • AZD1080, 10 mM in DMSO
  • AZD1080 ,S7145
  • 612487-72-6
  • Inhibitors
  • Akt
  • mTOR
  • PI3K